Goldman Sachs stock slips as bank rally cools, with earnings next week in focus

Goldman Sachs stock slips as bank rally cools, with earnings next week in focus

New York, January 7, 2026, 13:52 (EST) — Regular session

  • Goldman Sachs shares fell as big banks stepped back after a three-session run
  • Traders are weighing fresh U.S. labour data ahead of Friday’s payrolls report
  • Attention is shifting to bank earnings next week, including Goldman on Jan. 15

Shares of The Goldman Sachs Group Inc (GS.N) fell 1.3% to $942.97 in midday New York trading on Wednesday. The stock opened at $956.88 and swung between $942.00 and $959.68, with about 1.2 million shares traded.

Bank stocks slid after a three-session rally as investors digested weaker-than-expected U.S. job openings and a softer ADP private payrolls report. Bank of America was down about 2% and JPMorgan slipped after Wolfe Research cut it to “peer perform”; “The economic news sort of fueled a little bit of profit taking,” said Dakota Wealth’s Robert Pavlik. Traders now turn to Friday’s U.S. nonfarm payrolls report for December. Reuters

Next week brings a run of big-bank results, with JPMorgan set to report on Jan. 13 and Goldman and Morgan Stanley due on Jan. 15. Analysts expect a jump in investment banking revenue as dealmaking picked up, with global investment banking revenue rising 15% to nearly $103 billion and mergers and acquisitions volume climbing 42% to $5.1 trillion in 2025, Dealogic data showed. For Goldman, analysts expect earnings per share — a key profit measure — to fall about 4.9%, with Wells Fargo analysts pointing to softer private-banking net interest income, the spread between what a bank earns on loans and pays on deposits, and higher compensation costs. Reuters

A day earlier, Goldman got a public reminder of where it still dominates. LSEG data showed the bank led global M&A league tables in 2025, advising on $1.48 trillion of deals and earning $4.6 billion in M&A fees. “It was an extraordinary M&A market,” Goldman’s global co-head of M&A, Stephan Feldgoise, said in the bank’s 2026 M&A outlook. Reuters

Goldman also told clients this week that hedge-fund risk-taking stayed hot into year-end. In a prime brokerage note, the bank said stock-picking hedge funds returned 16.24% in 2025 and that gross leverage in its prime book rose to 292.8% in December — roughly $300 of long and short positions for every $100 of investor capital. Reuters

The backdrop is not clean. A Reuters columnist flagged lofty U.S. equity valuations as a pressure point for 2026, arguing they can leave markets more vulnerable to drawdowns that tend to chill deal flow and weigh on fee-heavy businesses. Reuters

In Goldman’s results, investors are likely to focus on whether advisory and underwriting momentum translates into fees, and how trading holds up after a strong run in markets. They will also watch expense discipline — especially compensation — and signs of client appetite in wealth and private banking.

Before that, Friday’s payrolls report will test the rate-cut narrative that has helped lift risk assets early in the year. Goldman’s next major catalyst is its Jan. 15 earnings report.

Stock Market Today

  • Chord Energy valuation: DCF shows ~75% undervalued after price weakness
    January 9, 2026, 5:17 AM EST. Chord Energy's stock trades at $94.29 after a 1.7% weekly gain, but the longer-term picture remains mixed. The shares are down 18.9% over the last year and 14.8% over three years, though they carry a large 5-year gain. A Discounted Cash Flow (DCF) analysis using a 2-stage Free Cash Flow to Equity model estimates an intrinsic value of about $383.29 per share, implying roughly a 75.4% gap versus the current price. The model cites a trailing twelve months FCF of about $947.9 million, with projections of $661.5 million in 2026 and $1,017 million by 2030. Note this is one approach with its own assumptions; other methods such as multiples could tell a different story. Investment views depend on holding horizon and risk tolerance.
Oklo stock jumps again on DOE radioisotope deal as investor focus shifts to permits
Previous Story

Oklo stock jumps again on DOE radioisotope deal as investor focus shifts to permits

Visa stock slips as DOJ antitrust fight stays in focus; 3 dates investors are circling
Next Story

Visa stock slips as DOJ antitrust fight stays in focus; 3 dates investors are circling

Go toTop